173 related articles for article (PubMed ID: 12110277)
21. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
22. Expression of multidrug resistance-related transporters in human breast carcinoma.
Kanzaki A; Toi M; Nakayama K; Bando H; Mutoh M; Uchida T; Fukumoto M; Takebayashi Y
Jpn J Cancer Res; 2001 Apr; 92(4):452-8. PubMed ID: 11346468
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma.
Liu B; Staren ED; Iwamura T; Appert HE; Howard JM
J Surg Res; 2001 Aug; 99(2):179-86. PubMed ID: 11469885
[TBL] [Abstract][Full Text] [Related]
24. Expression of lung resistance protein in epithelioid sarcoma in vitro and in vivo.
Kusakabe H; Iwasaki H; Sano K; Kiyokane K
Arch Dermatol Res; 2000 Jun; 292(6):292-300. PubMed ID: 10929770
[TBL] [Abstract][Full Text] [Related]
25. Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42.
Moran E; Cleary I; Larkin AM; Amhlaoibh RN; Masterson A; Scheper RJ; Izquierdo MA; Center M; O'Sullivan F; Clynes M
Eur J Cancer; 1997 Apr; 33(4):652-60. PubMed ID: 9274450
[TBL] [Abstract][Full Text] [Related]
26. Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy.
Li J; Li ZN; Yu LC; Bao QL; Wu JR; Shi SB; Li XQ
Lung Cancer; 2010 Jul; 69(1):116-22. PubMed ID: 19875192
[TBL] [Abstract][Full Text] [Related]
27. ATP-dependent activity and mitochondrial localization of drug efflux pumps in doxorubicin-resistant breast cancer cells.
Dartier J; Lemaitre E; Chourpa I; Goupille C; Servais S; Chevalier S; Mahéo K; Dumas JF
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1075-1084. PubMed ID: 28214549
[TBL] [Abstract][Full Text] [Related]
28. The endocytic receptor protein LRP-1 modulate P-glycoprotein mediated drug resistance in MCF-7 cells.
Henry A; Mauperin M; Devy J; Dedieu S; Chazee L; Hachet C; Terryn C; Duca L; Martiny L; Devarenne-Charpentier E; Btaouri HE
PLoS One; 2023; 18(9):e0285834. PubMed ID: 37768946
[TBL] [Abstract][Full Text] [Related]
29. Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade.
Komdeur R; Plaat BE; van der Graaf WT; Hoekstra HJ; Hollema H; van den Berg E; Zwart N; Scheper RJ; Molenaar WM
Eur J Cancer; 2003 May; 39(7):909-16. PubMed ID: 12706359
[TBL] [Abstract][Full Text] [Related]
30. Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications.
Berger W; Setinek U; Hollaus P; Zidek T; Steiner E; Elbling L; Cantonati H; Attems J; Gsur A; Micksche M
J Cancer Res Clin Oncol; 2005 Jun; 131(6):355-63. PubMed ID: 15856298
[TBL] [Abstract][Full Text] [Related]
31. In vitro modulation of P-glycoprotein, MRP-1 and BCRP expression by mangiferin in doxorubicin-treated MCF-7 cells.
Louisa M; Soediro TM; Suyatna FD
Asian Pac J Cancer Prev; 2014; 15(4):1639-42. PubMed ID: 24641381
[TBL] [Abstract][Full Text] [Related]
32. Binding and inhibition of drug transport proteins by heparin: a potential drug transporter modulator capable of reducing multidrug resistance in human cancer cells.
Chen Y; Scully M; Petralia G; Kakkar A
Cancer Biol Ther; 2014 Jan; 15(1):135-45. PubMed ID: 24253450
[TBL] [Abstract][Full Text] [Related]
33. The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer.
Hu WQ; Peng CW; Li Y
J Exp Clin Cancer Res; 2009 Nov; 28(1):144. PubMed ID: 19930704
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
[TBL] [Abstract][Full Text] [Related]
35. [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma].
Katsaros D; Fracchioli S; Arts HJ; de Vries EG; Danese S; Richiardi G; Arisio R; Gordini G; Van der Zee AG; Suurmeijer AJ; Massobrio M
Minerva Ginecol; 1999 Dec; 51(12):463-70. PubMed ID: 10767994
[TBL] [Abstract][Full Text] [Related]
36. [The clinical significance of P-glycoprotein, lung resistance protein and multidrug resistance related protein expressions in infiltrating breast carcinoma tissues].
Zuo WS; Wei L; Song XR; Wang XW; Wang MY; Wang YS; Yu ZY; Bi Y
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3142-5. PubMed ID: 17313768
[TBL] [Abstract][Full Text] [Related]
37. Induction of MRP5 and SMRP mRNA by adriamycin exposure and its overexpression in human lung cancer cells resistant to adriamycin.
Yoshida M; Suzuki T; Komiya T; Hatashita E; Nishio K; Kazuhiko N; Fukuoka M
Int J Cancer; 2001 Nov; 94(3):432-7. PubMed ID: 11745426
[TBL] [Abstract][Full Text] [Related]
38. Role of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines.
Welters MJ; Fichtinger-Schepman AM; Baan RA; Flens MJ; Scheper RJ; Braakhuis BJ
Br J Cancer; 1998 Feb; 77(4):556-61. PubMed ID: 9484811
[TBL] [Abstract][Full Text] [Related]
39. Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.
Arts HJ; Katsaros D; de Vries EG; Massobrio M; Genta F; Danese S; Arisio R; Scheper RJ; Kool M; Scheffer GL; Willemse PH; van der Zee AG; Suurmeijer AJ
Clin Cancer Res; 1999 Oct; 5(10):2798-805. PubMed ID: 10537344
[TBL] [Abstract][Full Text] [Related]
40. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts.
Kolfschoten GM; Hulscher TM; Pinedo HM; Boven E
Br J Cancer; 2000 Oct; 83(7):921-7. PubMed ID: 10970695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
